Coverage at a glance
| Indication | Coverage |
|---|---|
| Obesity / chronic weight management | Covered with PA |
Plan type: Commercial employer-sponsored plans. Each indication below lists the BMI and clinical thresholds, the prior-authorization documentation, and the published policy it comes from.
This varies by plan. Roughly 60 percent of UHC commercial members are in self-funded employer plans, where the employer decides whether anti-obesity drugs are covered. Many exclude them. The UHC standard formulary would cover you, but your employer's election is what governs. Check your summary of benefits or call the number on your card. OptumRx is the pharmacy benefit manager.
Coverage by indication
| BMI threshold | BMI 30 or higher, or BMI 27 or higher with at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, cardiovascular disease, or sleep apnea) |
| Step therapy | No step therapy through phentermine or orlistat is required. Six months of documented comprehensive lifestyle intervention is required. |
| Authorization length | Wegovy 5 months initial, Zepbound 6 months initial, 12 months continuation for both |
What the prior authorization needs:
- BMI within the threshold
- Six months of documented lifestyle intervention, with specific program descriptions, because vague documentation is denied
- Comorbidity documentation if BMI is 27 to 29.9
Source: UnitedHealthcare Pharmacy, PA Notification Weight Loss (2026 UnitedHealthcare Services Inc.). Official payer PA notification document (public URL, binary; framework confirmed via secondary sources citing this document and the UHC June 2026 pharmacy bulletin). Verified June 12, 2026. This row is marked lower confidence: the policy document was confirmed at its public URL but served as an unreadable file, so the policy number and framework were cross-checked against secondary sources.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list, then have your prescriber submit it.
- Start with the UnitedHealthcare prior-authorization letter template, which cites this plan's policy and the diagnosis codes a reviewer looks for. Pick the indication that matches your clinical picture.
- Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
- Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
- If your plan does not cover the indication you need, compare cash-pay options in the cost guide and the cheapest legitimate programs.
Frequently asked questions
Does UnitedHealthcare cover Wegovy and Zepbound?
It depends on your plan. UnitedHealthcare covers Wegovy and Zepbound for obesity with prior authorization under its standard commercial criteria, but about 60 percent of UHC commercial members are in self-funded employer plans that each decide whether to include the GLP-1 benefit. This reflects the published policy verified June 2026.
What does UnitedHealthcare require to approve Wegovy and Zepbound?
For obesity / chronic weight management: The BMI requirement is BMI 30 or higher, or BMI 27 or higher with at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, cardiovascular disease, or sleep apnea). No step therapy through phentermine or orlistat is required. Six months of documented comprehensive lifestyle intervention is required. Authorization runs wegovy 5 months initial, Zepbound 6 months initial, 12 months continuation for both.
Why might UnitedHealthcare deny Wegovy and Zepbound even if I meet the criteria?
Roughly 60 percent of UHC commercial members are in self-funded employer plans, where the employer decides whether anti-obesity drugs are covered. Many exclude them. The UHC standard formulary would cover you, but your employer's election is what governs. Check your summary of benefits or call the number on your card. OptumRx is the pharmacy benefit manager.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources and the row is marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit, so those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
